Adenosine Diphosphate-Induced Platelet Aggregation Might Contribute to Poor Outcomes in Atrial Fibrillation-Related Ischemic Stroke

被引:11
作者
Choi, Jae-Hyung [1 ]
Cha, Jae-Kwan [1 ]
Huh, Jae-Taeck [1 ]
机构
[1] Dong A Univ, Stroke Ctr, Pusan 602715, South Korea
关键词
Platelet aggregation; atrial fibrillation; ischemic stroke; adenosine diphosphate; CARDIOVASCULAR-DISEASE; CHADS(2) SCORE; ASPIRIN; RISK; WARFARIN; THERAPY;
D O I
10.1016/j.jstrokecerebrovasdis.2013.10.011
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Systemic atherosclerosis is involved in ischemic damages and cardioembolism after atrial fibrillation (AF)-related ischemic stroke (IS). Platelet activation is a critical factor in systemic atherosclerosis; however, there is little information regarding the role of platelet activation on the outcome of AF-related IS. We investigated the relationship between adenosine diphosphate (ADP)-induced platelet aggregation and the long-term outcomes of AF-related IS. We studied 249 patients who were exclusively treated with anticoagulation therapy after they had experienced AF-related IS. We evaluated their platelet function 5 days after admission to the hospital by using an optic platelet aggregometer test. We also assessed the prognoses of patients 90 days after the AF-related IS. Our results showed that ADP-induced platelet aggregation was positively correlated with CHA2DS2-VASc scores (r = .285, P < .01). Totally, 107 (43.0%) patients had a poor outcome at 90 days after IS. Univariate analysis showed that the following factors significantly contribute to a poor outcome: older age (odds ratio [OR] = 1.07, confidence interval [CI] 1.04-1.10, P < .01), a history of stroke (OR = 3.24, CI 1.61-6.53, P < .01), high scores on the National Institutes of Health Stroke Scale (NIHSS; OR = 1.25, CI 1.18-1.32, P < .01), increased white blood cell counts (OR = 1.12, CI 1.02-1.24, P < .01), high CHA2DS2-VASc scores (>= 5, OR = 7.31, CI 3.36-15.93, P = .025), and the highest tertile of ADP-induced platelet aggregation (>= 72%, OR = 3.17, CI 1.67-5.99, P < .01). Of these factors, high NIHSS scores (OR = 1.27, CI 1.20-1.36, P < .01), high CHA2DS2-VASc scores (OR = 4.69, CI 1.21-18.14, P = .03), and the highest tertile of ADP-induced platelet aggregation (OR = 2.49, CI 1.17-5.27, P = .02) were independently associated with a poor outcome at 90 days after IS. Therefore, our results suggest that platelet activation might affect the outcome of AF-related IS.
引用
收藏
页码:E215 / E220
页数:6
相关论文
共 20 条
[1]   ADP-induced platelet aggregation in acute ischemic stroke patients on aspirin therapy [J].
Cha, J. -K. ;
Jeon, H. -W. ;
Kang, M. -J. .
EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (12) :1304-1308
[2]   Hypersensitivity of platelets to adenosine diphosphate in patients with stable cardiovascular disease predicts major adverse events despite antiplatelet therapy [J].
Christie, Douglas J. ;
Kottke-Marchant, Kandice ;
Gorman, Robert T. .
PLATELETS, 2008, 19 (02) :104-110
[3]   Guidelines for the Prevention of Stroke in Patients With Stroke or Transient Ischemic Attack A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association [J].
Furie, Karen L. ;
Kasner, Scott E. ;
Adams, Robert J. ;
Albers, Gregory W. ;
Bush, Ruth L. ;
Fagan, Susan C. ;
Halperin, Jonathan L. ;
Johnston, S. Claiborne ;
Katzan, Irene ;
Kernan, Walter N. ;
Mitchell, Pamela H. ;
Ovbiagele, Bruce ;
Palesch, Yuko Y. ;
Sacco, Ralph L. ;
Schwamm, Lee H. ;
Wassertheil-Smoller, Sylvia ;
Turan, Tanya N. ;
Wentworth, Deidre .
STROKE, 2011, 42 (01) :227-276
[4]   Low response to clopidogrel is associated with cardiovascular outcome after coronary stent implantation [J].
Geisler, Tobias ;
Langer, Harald ;
Wydymus, Magdalena ;
Goehring, Katrin ;
Zuern, Christine ;
Bigalke, Boris ;
Stellos, Konstantinos ;
May, Andreas E. ;
Gawaz, Meinrad .
EUROPEAN HEART JOURNAL, 2006, 27 (20) :2420-2425
[5]   A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease [J].
Gum, PA ;
Kottke-Marchant, K ;
Welsh, PA ;
White, J ;
Topol, EJ .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) :961-965
[6]   Evaluation of dose-related effects of aspirin on platelet function - Results from the aspirin-induced platelet effect (ASPECT) study [J].
Gurbel, Paul A. ;
Bliden, Kevin P. ;
DiChiara, Joseph ;
Newcomer, Justin ;
Weng, Willy ;
Neerchal, Nagaraj K. ;
Gesheff, Tania ;
Chaganti, Srivasavi K. ;
Etherington, Amena ;
Tantry, Udaya S. .
CIRCULATION, 2007, 115 (25) :3156-3164
[7]   Frequency and significance of cardiac sources of embolism in the TOAST classification [J].
Han, Sang Won ;
Nam, Hyo Suk ;
Kim, Seo Hyun ;
Lee, Jong Yun ;
Lee, Kyung-Yul ;
Heo, Ji Hoe .
CEREBROVASCULAR DISEASES, 2007, 24 (05) :463-468
[8]   Intracranial Hemorrhage in Atrial Fibrillation Patients During Anticoagulation With Warfarin or Dabigatran The RE-LY Trial [J].
Hart, Robert G. ;
Diener, Hans-Christoph ;
Yang, Sean ;
Connolly, Stuart J. ;
Wallentin, Lars ;
Reilly, Paul A. ;
Ezekowitz, Michael D. ;
Yusuf, Salim .
STROKE, 2012, 43 (06) :1511-+
[9]   Survival after stroke - The impact of CHADS2 score and atrial fibrillation [J].
Henriksson, Karin M. ;
Farahmand, Bahman ;
Johansson, Saga ;
Asberg, Signild ;
Terent, Andreas ;
Edvardsson, Nils .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2010, 141 (01) :18-23
[10]   Early neurological outcomes according to CHADS2 score in stroke patients with non-valvular atrial fibrillation [J].
Hong, H. J. ;
Kim, Y. D. ;
Cha, M. -J. ;
Kim, J. ;
Lee, D. H. ;
Lee, H. S. ;
Nam, C. M. ;
Nam, H. S. ;
Heo, J. H. .
EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 (02) :284-290